Mangoceuticals, Inc.
MGRX
$0.34
$0.000.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.64% | -40.67% | -11.91% | -148.38% | 2.54% |
| Total Depreciation and Amortization | 1,706.85% | -97.03% | 101.49% | -42.50% | 2,588.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -292.18% |
| Total Other Non-Cash Items | -99.03% | 111.28% | 62.16% | 292.23% | -17.06% |
| Change in Net Operating Assets | 353.67% | -577.96% | -39.39% | 196.12% | 481.72% |
| Cash from Operations | 13.17% | 1.20% | 44.77% | -101.38% | 3.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 36.59% | -6.31% | 52.49% | 49.34% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 187.50% | -46.67% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.48% | 26.61% | -43.95% | 103.56% | 49.67% |
| Foreign Exchange rate Adjustments | -- | -100.00% | -97.37% | 192.68% | -1,540.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.29% | 1,452.24% | 37.64% | 216.34% | 96.32% |